Prevent premature deaths from heart failure, urges the Heart Failure Association

Key points
- The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure.
- Heart failure is a serious condition in which the heart is unable to pump enough blood to meet the needs of the body.
- The Heart Failure Association (HFA) is a registered branch of the ESC.
- Eur J Heart Fail 2008;10:933-89. doi: 10.1016/j.ejheart.2008.08.005 2.
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death worldwide, will be presented at an endorsement event on 16 May 2014 in Athens, Greece, immediately before the Heart Failure 2014 Congress.
Approximately 15 million people are living with heart failure in Europe, and 26 million worldwide. The outlook is poor: survival rates are worse than those for bowel, breast or prostate cancer, and the illness imposes a huge burden on patients, caregivers and healthcare systems. Heart failure accounts for around 1 - 2% of the total healthcare budget in developed countries.3 In Germany alone, the total medical costs attributable to the disease were nearly €3 billion in 2006. In the coming decades, the global rise of ageing populations and detrimental lifestyle changes could more than double the demands on healthcare systems in some countries. This represents a burgeoning health and economic crisis which must be addressed.
Awareness of the disease is alarmingly poor among the general public and healthcare professionals alike, resulting in many unnecessary premature deaths.
“Although there is no cure, heart failure can be prevented, and most patients can be treated effectively to improve quality of life and survival,” stressed Professor Stefan Anker, President of the HFA. “People need to recognise the symptoms of heart failure to help increase the opportunities for prevention,” added Professor Piotr Ponikowski, Past President of the HFA. “Policy initiatives that prioritise heart failure prevention and champion equity of care for all would ease the strain on global healthcare systems and improve outcomes for patients.”
Heart failure: preventing disease and death worldwide has been developed as part of the Global Heart Failure Awareness Programme initiated by the HFA of the ESC. Written by a distinguished author group led by Professor Piotr Ponikowski (Wrocław, Poland) and including Professor Stefan Anker (Berlin, Germany) and Professor Gerasimos Filippatos (Athens, Greece), it will be presented at an endorsement event on 16 May 2014 in Athens. Its aim is to raise awareness of heart failure across Europe and beyond.
“It is a great pleasure to host this auspicious international event,” stated Professor Filippatos, Heart Failure 2014 Scientific Chairperson and HFA President-Elect. “Here in Greece, there is substantial power to improve national health by increasing public awareness of heart failure and encouraging the type of healthy lifestyle that reduces risk.”
The white paper examines the worldwide burden of heart failure and highlights the challenges of dealing with the disease, with a clear Call to Action for policy-makers. The evidence-based recommendations for policy change include:
1. Promoting heart failure prevention through public awareness programmes.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsDeaths higher for heart attack patients at night and weekends
Mortality is higher, and emergency treatment takes longer, for heart attack patients who arrive at hospital during the night or at weekends compared with regular hours, finds a study published on bmj.com today. The…
22 January 2014
NewsLong-lasting gene therapy benefits advanced heart failure patients
Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on…
20 November 2013
NewsPhysical fitness improves survival, prevents some heart attacks
A new study highlights the importance of exercise and physical fitness among people with stable coronary artery disease. Researchers at the Johns Hopkins University School of Medicine and Henry Ford Hospital found that…






